Summary:
Healthy adults aged 18 years and older are needed to participate in the study of an Influenza (FLU) vaccine. The study will evaluate the safety of the vaccine and its ability to generate an immune response against Influenza.
Qualified volunteers may receive:
- Reimbursement for time and travel (Up to $3,500+)
- 56 weeks of study related treatment at no cost
Apply today to see if you qualify for this exciting new opportunity.
Criteria:- Aged 18 and older
- Cannot have any of the following:
- Asthma
- Neurological and neurodevelopmental conditions (such as cerebral palsy, epilepsy [seizure disorders], stroke, intellectual disability, moderate to severe developmental delay, muscular dystrophy, or spinal cord injury)
- Chronic lung disease (such as chronic obstructive pulmonary disease [COPD], emphysema, and cystic fibrosis)
- Heart disease (such as congenital heart disease, congestive heart failure and coronary artery disease)
- Blood disorders (such as sickle cell disease and Thalassemia)
- Endocrine disorders (such as diabetes and adrenal insufficiency)
- Chronic kidney disease
- Chronic liver disease
- Metabolic disorders (such as inherited metabolic disorders and mitochondrial disorders)
- Weakened immune system due to disease or medication (such as individuals with HIV or AIDS, or cancer, or those on chronic steroids)
- People younger than 19 years of age who are receiving long-term aspirin therapy
Qualified Participants May Receive:
- Reimbursement for time and travel (Up to $3,500+)
- 56 weeks of study related treatment at no cost